Affiliation:
1. Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China
2. Shineway Pharmaceutical Group Limited, Shijiazhuang, China
3. World Federation of Chinese Medicine Societies, Beijing, China
4. China-Japan Friendship Hospital, Beijing, China
Abstract
Background:
To investigate the potential active ingredients and possible mechanisms of Shujin Tongluo granules (SJTLG) in the treatment of cervical spondylosis (CS) by network pharmacology and molecular docking.
Methods:
The active ingredients and potential targets of SJTLG were obtained through databases such as traditional Chinese medicine system (TCMSP) and BATMAN-traditional Chinese medicine (TCM), and the relevant human targets of CS were identified through databases such as OMIM, GeneCards, and DisGeNET. The intersection targets were imported into STRING for protein-protein interaction (PPI) analysis. The obtained data were imported into Cytoscape 3.9.0 software for visualization, and module analysis was performed using the MCODE plug-in. The representative targets were screened through the Metascape website for pathway enrichment analysis in Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Cytoscape software was used to build networks such as “drug-compound-target” and “drug-compound-target-pathway.” Finally, the key targets were selected for molecular docking with the corresponding compounds by Autodock Tools 1.5.7 and visualized by PyMol.
Results:
A total of 132 active compounds and 996 targets from SJTLG and 678 targets from CS were screened with 116 intersection targets. The key targets were AKT1, GAPDH, ALB, IL-6, TP53, TNF, VEGFA, IL-1β, EGFR, HSP90AA1, ESR1, and JUN. The results of GO and KEGG enrichment analysis showed that the treatment of CS was mainly related to biological processes such as cellular response to nitrogen compound, cellular response to organonitrogen compound, and positive regulation of locomotion, and the targets were mainly focused on pathways in cancer, Kaposi sarcoma-associated herpesvirus infection, PI3K-Akt signaling pathway, lipid, and atherosclerosis. Molecular docking results showed that the minimum binding energy between the core targets and the corresponding compound was <−5.0 kcal·mol−1.
Conclusion:
This study preliminarily elucidates the potential active ingredients and mechanism of anti-inflammatory, analgesic, microcirculation improvement, vasodilation, osteoporosis inhibition and nerve nutrition effects of SJTLG in the treatment of CS and provides a reference for its clinical application.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference41 articles.
1. Postoperative hematoma in cervical spondylosis patient complicated with Huntington’s disease: case report and literature review.;Zhang;SAGE Open Med Case Rep,2023
2. Impact of Standardized rehabilitation therapy on the long-term efficacy of rehabilitation therapy for patients with cervical spondylosis.;China Standard,2022
3. Relationship between muscle system lesions around cervical vertebra and cervical spondylosis.;Ye;Chin J Bone Jt Inj,2005
4. Degenerative cervical myelopathy: recognition and management.;Kane Shawn;Am Fam Physician,2020
5. Clinical practice guidelines in traditional Chinese medicine rehabilitation--cervical spondylosis (Xiangbi).;Zhang;Rehabil Med,2020